Download presentation
Presentation is loading. Please wait.
Published byMalle Aasa Modified over 6 years ago
1
Relapsed/Refractory Myeloma: Foundational Knowledge Essential to Improve Patient Outcomes
4
Case Study
11
Relapsed Multiple Myeloma What Do You Do With Patients After RVD?
13
Cytogenetics A Parameter That, in Isolation, Should Be Used With Caution
19
Should Consolidation Therapy Be Considered After HDT/ASCT? Yes!
20
Relapsed and/or Refractory MM When to Use the Next Generation of the Existing Class of Agents and When to Use a New Class of Agents
21
Relapsed and/or Refractory MM Novel mAbs
23
Relapsed and/or Refractory MM Novel Proteasome Inhibitors
25
Relapsed and/or Refractory MM Pomalidomide, a Third-Generation IMiD
27
Relapsed and/or Refractory MM Small Molecule Inhibitors
31
Thank you for participating in this activity.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.